No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr20:23016200-23028200 |
Weak transcription |
Aorta |
Aorta
|
2 |
chr20:23021000-23026800 |
Weak transcription |
HMEC |
breast
|
3 |
chr20:23021600-23027000 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
4 |
chr20:23024200-23028200 |
Weak transcription |
Pancreas |
Pancrea
|
5 |
chr20:23024600-23031400 |
Weak transcription |
K562 |
blood
|
6 |
chr20:23024800-23026600 |
Weak transcription |
Stomach Mucosa |
stomach
|
7 |
chr20:23024800-23027000 |
Weak transcription |
Gastric |
stomach
|
8 |
chr20:23025200-23026600 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
9 |
chr20:23025400-23027000 |
Bivalent Enhancer |
Primary neutrophils fromperipheralblood |
blood
|
10 |
chr20:23025800-23026800 |
Weak transcription |
Placenta |
Placenta
|
11 |
chr20:23025800-23026800 |
Enhancers |
Skeletal Muscle Female |
skeletal muscle
|
12 |
chr20:23025800-23027000 |
Active TSS |
Right Atrium |
heart
|
13 |
chr20:23025800-23028000 |
Weak transcription |
Spleen |
Spleen
|
14 |
chr20:23025800-23028400 |
Transcr. at gene 5' and 3' |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
15 |
chr20:23026000-23026600 |
Enhancers |
Skeletal Muscle Male |
skeletal muscle
|
16 |
chr20:23026000-23027000 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
17 |
chr20:23026000-23032400 |
Active TSS |
Pancreatic Islets |
Pancreatic Islet
|
18 |
chr20:23026200-23026600 |
Active TSS |
Duodenum Smooth Muscle |
Duodenum
|
19 |
chr20:23026200-23026800 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
20 |
chr20:23026200-23026800 |
Active TSS |
HSMMtube |
muscle
|
21 |
chr20:23026200-23027000 |
Active TSS |
Psoas Muscle |
Psoas
|
22 |
chr20:23026200-23027200 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
23 |
chr20:23026200-23027200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
24 |
chr20:23026400-23026600 |
Flanking Active TSS |
Adipose Nuclei |
Adipose
|
25 |
chr20:23026400-23026600 |
Enhancers |
Esophagus |
oesophagus
|
26 |
chr20:23026400-23026600 |
Active TSS |
A549 |
lung
|
27 |
chr20:23026400-23026800 |
Enhancers |
HSMM |
muscle
|
28 |
chr20:23026400-23026800 |
Bivalent/Poised TSS |
Monocytes-CD14+_RO01746 |
blood
|
29 |
chr20:23026400-23026800 |
Enhancers |
NHDF-Ad |
bronchial
|
30 |
chr20:23026400-23027000 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
31 |
chr20:23026400-23027000 |
Bivalent Enhancer |
Fetal Lung |
lung
|
32 |
chr20:23026400-23027000 |
Active TSS |
Lung |
lung
|
33 |
chr20:23026400-23027600 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
34 |
chr20:23026400-23027600 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
35 |
chr20:23026400-23028400 |
Bivalent/Poised TSS |
Stomach Smooth Muscle |
stomach
|